|
|
||||||||
Journal of General Virology, Vol 79, 371-374, Copyright © 1998 by Society for General Microbiology
ARTICLES |
RC Elston, S Napthine and J Doorbar
Division of Virology, National Institute for Medical Research, London, UK. relston@nimr.mrc.ac.uk
A 16-mer peptide library was screened using the yeast two-hybrid system to identify peptides which specifically interact with the human papillomavirus type 16 (HPV-16) E6 protein. Four different peptides were identified, three of which contained an E-L-L/V-G motif. A fifth E6 binding peptide, derived from the putative tumour suppressor protein tuberin, was identified during a two-hybrid screen of a HeLa cDNA expression library. This peptide contained a D-I-L-G motif. Homology to the peptides was found within the E6 binding proteins E6-AP and E6-BP. A synthetic peptide containing the ELLG motif blocked the interaction of E6 with both E6-AP and E6-BP. The data suggest that E6 interacts through a structurally similar binding domain present within a number of cellular proteins.
This article has been cited by other articles:
![]() |
X. Liu, A. Dakic, Y. Zhang, Y. Dai, R. Chen, and R. Schlegel HPV E6 protein interacts physically and functionally with the cellular telomerase complex PNAS, November 3, 2009; 106(44): 18780 - 18785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Tungteakkhun, M. Filippova, J. W. Neidigh, N. Fodor, and P. J. Duerksen-Hughes The Interaction between Human Papillomavirus Type 16 and FADD Is Mediated by a Novel E6 Binding Domain J. Virol., October 1, 2008; 82(19): 9600 - 9614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wade, N. Brimer, and S. Vande Pol Transformation by Bovine Papillomavirus Type 1 E6 Requires Paxillin J. Virol., June 15, 2008; 82(12): 5962 - 5966. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein J. Biol. Chem., March 18, 2005; 280(11): 10807 - 10816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Munger, A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh Mechanisms of Human Papillomavirus-Induced Oncogenesis J. Virol., November 1, 2004; 78(21): 11451 - 11460. [Full Text] [PDF] |
||||
![]() |
Z. Lu, X. Hu, Y. Li, L. Zheng, Y. Zhou, H. Jiang, T. Ning, Z. Basang, C. Zhang, and Y. Ke Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin J. Biol. Chem., August 20, 2004; 279(34): 35664 - 35670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippova, L. Parkhurst, and P. J. Duerksen-Hughes The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis J. Biol. Chem., June 11, 2004; 279(24): 25729 - 25744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Nguyen, M. M. Nguyen, D. Lee, A. E. Griep, and P. F. Lambert The PDZ Ligand Domain of the Human Papillomavirus Type 16 E6 Protein Is Required for E6's Induction of Epithelial Hyperplasia In Vivo J. Virol., June 15, 2003; 77(12): 6957 - 6964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nguyen, S. Song, A. Liem, E. Androphy, Y. Liu, and P. F. Lambert A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo J. Virol., November 13, 2002; 76(24): 13039 - 13048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filippova, H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen-Hughes The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis J. Biol. Chem., June 7, 2002; 277(24): 21730 - 21739. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Gao, A. Kumar, L. Singh, J. M. Huibregtse, S. Beaudenon, S. Srinivasan, D. E. Wazer, H. Band, and V. Band Human Papillomavirus E6-induced Degradation of E6TP1 Is Mediated by E6AP Ubiquitin Ligase Cancer Res., June 1, 2002; 62(11): 3315 - 3321. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bohl, B. Hull, and S. B. Vande Pol Cooperative Transformation and Coexpression of Bovine Papillomavirus Type 1 E5 and E7 Proteins J. Virol., January 1, 2001; 75(1): 513 - 521. [Abstract] [Full Text] |
||||
![]() |
J. Doorbar, R. C. Elston, S. Napthine, K. Raj, E. Medcalf, D. Jackson, N. Coleman, H. M. Griffin, P. Masterson, S. Stacey, et al. The E1and E4 Protein of Human Papillomavirus Type 16 Associates with a Putative RNA Helicase through Sequences in Its C Terminus J. Virol., November 1, 2000; 74(21): 10081 - 10095. [Abstract] [Full Text] |
||||
![]() |
Y. Liu, J. J. Chen, Q. Gao, S. Dalal, Y. Hong, C. P. Mansur, V. Band, and E. J. Androphy Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells J. Virol., September 1, 1999; 73(9): 7297 - 7307. [Abstract] [Full Text] |
||||
![]() |
C. Kuhne and L. Banks E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7 to the Ubiquitination Pathway by a Novel Motif, the L2G Box J. Biol. Chem., December 18, 1998; 273(51): 34302 - 34309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Ronco, A. Y. Karpova, M. Vidal, and P. M. Howley Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity Genes & Dev., July 1, 1998; 12(13): 2061 - 2072. [Abstract] [Full Text] |
||||
![]() |
K. Butz, C. Denk, A. Ullmann, M. Scheffner, and F. Hoppe-Seyler Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein PNAS, June 6, 2000; 97(12): 6693 - 6697. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |